Claus Zieler, Chief Commercial & Medical Affairs Officer, Astellas Pharma discusses the barriers preventing patients from accessing innovative medicines at the scale at which they’re being devleoped and approved. Strong innovation, uneven access Innovation in medicines is accelerating globally. In oncology, immunology, rare diseases, and other specialty areas, scientific advances are translating into more targeted… Read More
News round-up for 13 – 17 July by Bruno Quinney, Content Team at DDW. This week, a new drug has shown potential to treat heart disease. Elsewhere, Cancer Research UK is leading a global cancer trial. The top stories: New drug could treat common heart disease, study… Read More
Ben Sidders, Chief Scientific Officer at Biorelate, explores how emerging AI-driven technologies are revealing hidden cause-and-effect relationships within existing biomedical data. Nearly 30% of FDA-approved drugs eventually gain additional indications beyond their original approval and are some of the highest-value and… Read More
DDW’s Diana Turner speaks to Catherine Whittington, Associate Professor in the Department of Biomedical… Read More
Dr Saška Brajkovic, Senior Director R&D, Lunaphore, Spatial Biology Division at Bio-Techne, explains how the spatial biology field is transforming our view of how various diseases function and leading to exciting new treatment possibilities. Spatial biology is rapidly gaining momentum across biomedical research. At the end of 2024, the field… Read More
Optibrium has partnered with Tallinn University of Technology (TalTech) to co-supervise an EU-funded PhD position as part of the INNOCHEMBIO programme1. This research project will focus on developing more accurate metabolism models that will reduce the reliance on costly laboratory experiments while improving speed, efficiency and sustainability in drug discovery. Read More
To celebrate Research Appreciation Day 2025 on 5 July, DDW’s Diana Turner has collated the best career advice from our Meet the Researcher interviewees over the last year. Enjoy what you do “It is important to enjoy what you do, as it takes a lot of your time and… Read More
BioMed X, an independent biomedical research institute based in Heidelberg, Germany, has announced the launch of its XBridge Program, a fast-track initiative designed to support US-based biomedical researchers impacted by the current NIH funding gaps, hiring freezes, and grant terminations. The programme is a kind of matchmaking… Read More
Rare Disease Day is an observance held on the last day of February annually to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. To mark Rare Disease Day 2025, DDW gathered insight from a range of industry… Read More
Arena BioWorks has launched as a biomedical research institute with a stated mission to uncover mechanisms of disease by engaging in basic biological research that will be translated into lifesaving biotech therapeutics. Arena BioWorks describes itself as a dual-purpose entity aimed at achieving social good and… Read More
DDW’s Megan Thomas speaks to Jennifer Cann, Director of Pathology at Virscio, a company solving human health challenges through biomedical research. MT: Can you provide a top line summary of your research? JC: As Virscio’s Director of Pathology, I provide exploratory and translational pathology… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The most impactful drug discovery news this week is all linked with scientific research… Read More
News round-up for 17-21 July by DDW Digital Content Editor Diana Spencer. The most impactful drug discovery news this week is all linked with scientific research data. Analysts Phesi revealed that a third of clinical development programmes are cancelled during Phase II, and there were significant… Read More
UK-based precision medicine software provider Lifebit has agreed partnerships with two population genomic initiatives in Mexico and Brazil to help diversify genomic research and reduce health inequality in Latin America. Lifebit’s platform provides a secure way for research organisations to access global biomedical data – helping… Read More
Neuroscientist Yichao Yu has been chosen to receive ELRIG’s Research & Innovation 2023 Early Career Professional Impact Award. Yu is a neuroscientist at University College London’s Centre for Advanced Biomedical Imaging. He develops and utilises innovative technologies such as magnetomechanical stimulation (MMS) to remotely and precisely… Read More
Ahead of the UK Government’s Autumn Statement on Thursday, leading biomedical research companies, charities and institutions have called for the Chancellor to place medical and health research at the heart of plans for growth. The letter has been signed by the Academy of Medical Sciences, Pfizer, Wellcome,… Read More
